Understanding ANKRD55: A Potential Drug Target for ANKRD55 (G79722)

Target Name: ANKRD55

NCBI ID: G79722

ANKRD55

Understanding ANKRD55: A Potential Drug Target for ANKRD55

ANKRD55 (MGC126014) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of proteins known as the K-type ATP-binding proteins (K-ATPases) , which are a family of transmembrane proteins that span multiple species. K-ATPases are known for their ability to generate ATP through a unique mechanism of ATP synthase, in which the enzyme ATP synthase is composed of a protein domain that is both ATP-binding and catalytic.

The ANKRD55 protein is of particular interest as a potential drug target or biomarker because of its ability to regulate the production of ATP in various tissues. In addition, ANKRD55 has been shown to play a role in a variety of physiological processes, including cell signaling, metabolism, and inflammation.

The ANKRD55 protein is composed of a variable-length cytoplasmic tail that is made up of various domains, including an N-terminal transmembrane domain, a catalytic domain, and a C-terminal T-cell antigen (TCA) domain. The N-terminal transmembrane domain is responsible for the protein's ability to interact with various membrane receptors, while the catalytic domain is responsible for the protein's ability to catalyze the production of ATP through its ATP-binding site.

The ANKRD55 protein is expressed in a variety of tissues and organs, including the brain, heart, and kidneys. It has been shown to be expressed in the brain, where it is a component of the protein complex known as the Ca2+-ATP-dependent chloride channel (CAC), which is involved in the regulation of intracellular calcium levels. The CAC is known to play a role in a variety of physiological processes, including muscle contraction, neurotransmitter release, and pain perception.

In addition to its expression in the brain, ANKRD55 has also been shown to be expressed in other tissues and organs, including the heart and the kidneys. It is involved in the regulation of various physiological processes in these tissues, including the contraction and relaxation of blood vessels, blood pressure, and kidney function.

The ANKRD55 protein is also of particular interest as a potential drug target because of its ability to regulate the production of ATP in various tissues. ATP is a critical energy source for many cellular processes, including muscle contractions, neural transmission, and immune function. The ATP by the ANKRD55 protein is regulated by various intracellular signaling pathways, including the production regulation of ion channels, protein kinase, and transcription factors.

The ANKRD55 protein has also been shown to play a role in the regulation of inflammation. It is a component of several signaling pathways that are involved in the regulation of inflammation, including the production of pro-inflammatory cytokines and the regulation of immune cell function.

In conclusion, ANKRD55 is a protein that is expressed in various tissues of the body and is involved in a variety of physiological processes. Its ability to regulate the production of ATP and its involvement in the regulation of inflammation make it an attractive target for research and development of new drugs. Further studies are needed to fully understand the ANKRD55 protein's role in these processes and to determine its potential as a drug target.

Protein Name: Ankyrin Repeat Domain 55

The "ANKRD55 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD55 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets